Clinical Trial: Short-term Effect of Extended-release Niacin on Endothelial Function.

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Short-term Effect of Extended-release Niacin With and Without the Addition of Laropiprant on Endothelial Function

Brief Summary: Individuals with reduced plasma concentration of high-density lipoprotein (HDL) cholesterol are more susceptible to oxidative stress and often present reduced endothelial function, which has been mainly related to this susceptibility. Studies in animal and cell models have demonstrated that niacin activates both GPR-109A in leukocytes and heme oxygenase-1 (HO-1) pathway promoting strong anti-inflammatory and anti-oxidative effects. . In this context, the aim of this study was to investigate the short-term effect of niacin on endothelial function and verify the existence of interaction of PGD2 receptor antagonist, i.e. laropiprant (LRPT), in subjects with low HDL-cholesterol (HDL -C).